As shown in Fig. 3f, although anti-IL-17R antibody alone did not significantly affect cell viability, it significantly inhibited the proliferation of B-ALL cells in the presence of IL-17A. This evidence concerns the gene IL17A and precursor B-cell acute lymphoblastic leukemia.